Taysha Gene Therapies Statistics
Total Valuation
TSHA has a market cap or net worth of $1.40 billion. The enterprise value is $1.15 billion.
Important Dates
The next estimated earnings date is Wednesday, November 12, 2025, after market close.
Earnings Date | Nov 12, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
TSHA has 272.79 million shares outstanding. The number of shares has increased by 37.81% in one year.
Current Share Class | 272.79M |
Shares Outstanding | 272.79M |
Shares Change (YoY) | +37.81% |
Shares Change (QoQ) | +10.65% |
Owned by Insiders (%) | 10.65% |
Owned by Institutions (%) | 69.54% |
Float | 173.43M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 172.45 |
Forward PS | 219.18 |
PB Ratio | 5.55 |
P/TBV Ratio | 5.63 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 141.74 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.48, with a Debt / Equity ratio of 0.24.
Current Ratio | 12.48 |
Quick Ratio | 12.34 |
Debt / Equity | 0.24 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -1,087.39 |
Financial Efficiency
Return on equity (ROE) is -51.86% and return on invested capital (ROIC) is -23.43%.
Return on Equity (ROE) | -51.86% |
Return on Assets (ROA) | -20.88% |
Return on Invested Capital (ROIC) | -23.43% |
Return on Capital Employed (ROCE) | -28.95% |
Revenue Per Employee | $110,932 |
Profits Per Employee | -$1.27M |
Employee Count | 73 |
Asset Turnover | 0.03 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +154.73% in the last 52 weeks. The beta is 0.97, so TSHA's price volatility has been similar to the market average.
Beta (5Y) | 0.97 |
52-Week Price Change | +154.73% |
50-Day Moving Average | 3.19 |
200-Day Moving Average | 2.31 |
Relative Strength Index (RSI) | 75.08 |
Average Volume (20 Days) | 11,408,204 |
Short Selling Information
The latest short interest is 43.36 million, so 15.89% of the outstanding shares have been sold short.
Short Interest | 43.36M |
Short Previous Month | 40.78M |
Short % of Shares Out | 15.89% |
Short % of Float | 25.00% |
Short Ratio (days to cover) | 12.38 |
Income Statement
In the last 12 months, TSHA had revenue of $8.10 million and -$92.72 million in losses. Loss per share was -$0.34.
Revenue | 8.10M |
Gross Profit | 8.10M |
Operating Income | -89.17M |
Pretax Income | -92.72M |
Net Income | -92.72M |
EBITDA | -88.01M |
EBIT | -89.17M |
Loss Per Share | -$0.34 |
Full Income Statement Balance Sheet
The company has $312.76 million in cash and $59.76 million in debt, giving a net cash position of $253.00 million or $0.93 per share.
Cash & Cash Equivalents | 312.76M |
Total Debt | 59.76M |
Net Cash | 253.00M |
Net Cash Per Share | $0.93 |
Equity (Book Value) | 248.73M |
Book Value Per Share | 0.91 |
Working Capital | 290.92M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$82.13 million and capital expenditures -$413,000, giving a free cash flow of -$82.54 million.
Operating Cash Flow | -82.13M |
Capital Expenditures | -413,000 |
Free Cash Flow | -82.54M |
FCF Per Share | -$0.30 |
Full Cash Flow Statement Margins
Gross Margin | 100.00% |
Operating Margin | -1,101.09% |
Pretax Margin | -1,144.97% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
TSHA does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -37.81% |
Shareholder Yield | -37.81% |
Earnings Yield | -6.62% |
FCF Yield | -5.89% |
Analyst Forecast
The average price target for TSHA is $9.38, which is 82.31% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $9.38 |
Price Target Difference | 82.31% |
Analyst Consensus | Strong Buy |
Analyst Count | 8 |
Revenue Growth Forecast (5Y) | 124.62% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
TSHA has an Altman Z-Score of 0.43 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 0.43 |
Piotroski F-Score | 2 |